Edvan Crusoé

706 total citations
4 papers, 29 citations indexed

About

Edvan Crusoé is a scholar working on Hematology, Molecular Biology and Surgery. According to data from OpenAlex, Edvan Crusoé has authored 4 papers receiving a total of 29 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hematology, 3 papers in Molecular Biology and 1 paper in Surgery. Recurrent topics in Edvan Crusoé's work include Multiple Myeloma Research and Treatments (4 papers), Protein Degradation and Inhibitors (3 papers) and Platelet Disorders and Treatments (1 paper). Edvan Crusoé is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Protein Degradation and Inhibitors (3 papers) and Platelet Disorders and Treatments (1 paper). Edvan Crusoé collaborates with scholars based in Brazil, Argentina and United States. Edvan Crusoé's co-authors include Rosane Bittencourt, Dorotea Fantl, Carlos Chiattone, Ângelo Maiolino, Vânia Hungria, Eliana Miranda, Patricio G. Schlottmann, Jacek Czepiel, Anna Waszczuk‐Gajda and Jorge J. Castillo and has published in prestigious journals such as Blood, Annals of Hematology and Oncology and Therapy.

In The Last Decade

Edvan Crusoé

3 papers receiving 29 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edvan Crusoé Brazil	2	28	18	15	8	2	4	29
Maryana Simonova Greece	3	28 1.0×	23 1.3×	15 1.0×	6 0.8×	2 1.0×	4	29
Cristina Nevado García Spain	3	25 0.9×	21 1.2×	16 1.1×	4 0.5×	2 1.0×	8	35
Debbie Hastings United States	3	21 0.8×	20 1.1×	13 0.9×	7 0.9×	3 1.5×	7	30
Juan Bargay Spain	3	33 1.2×	17 0.9×	12 0.8×	9 1.1×		4	38
Lydia Eccersley United Kingdom	3	20 0.7×	17 0.9×	13 0.9×	5 0.6×		9	28
Olga Shvetz Israel	3	22 0.8×	19 1.1×	16 1.1×	4 0.5×		6	26
Melina Arazy United States	2	36 1.3×	32 1.8×	22 1.5×	4 0.5×	3 1.5×	2	37
Carolina Lonardi United States	3	23 0.8×	20 1.1×	28 1.9×	4 0.5×		14	36
Brianna Berrios United States	3	26 0.9×	21 1.2×	15 1.0×	4 0.5×	1 0.5×	4	37
Cécile Sonntag France	2	22 0.8×	19 1.1×	11 0.7×	3 0.4×		3	23

Countries citing papers authored by Edvan Crusoé

Since Specialization

Citations

This map shows the geographic impact of Edvan Crusoé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edvan Crusoé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edvan Crusoé more than expected).

Fields of papers citing papers by Edvan Crusoé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edvan Crusoé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edvan Crusoé. The network helps show where Edvan Crusoé may publish in the future.

Co-authorship network of co-authors of Edvan Crusoé

This figure shows the co-authorship network connecting the top 25 collaborators of Edvan Crusoé. A scholar is included among the top collaborators of Edvan Crusoé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edvan Crusoé. Edvan Crusoé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Hungria, Vânia, Edvan Crusoé, Michel Eid Farah, et al.. (2025). Practical Guidance on the Clinical Management of Ocular Adverse Events Associated with Belantamab Mafodotin for Patients with Relapsed/Refractory Multiple Myeloma: Latin American Expert Panel Recommendations. Oncology and Therapy. 13(3). 797–810.

2.

Jurczyszyn, Artur, Alessandro Gozzetti, Joanna Gdula‐Argasińska, et al.. (2017). Similar survival outcomes in patients with biclonal versus monoclonal myeloma: a multi-institutional matched case-control study. Annals of Hematology. 96(10). 1693–1698. 6 indexed citations

3.

Hungria, Vânia, Edvan Crusoé, Ângelo Maiolino, et al.. (2015). Phase 3 trial of three thalidomide-containing regimens in patients with newly diagnosed multiple myeloma not transplant-eligible. Annals of Hematology. 95(2). 271–278. 22 indexed citations

4.

Crusoé, Edvan, Ângelo Maiolino, Rosane Bittencourt, et al.. (2011). A Phase III Study Comparing Thalidomide/Cyclophosphamide/ Dexa Vs Thalidomide/Dexa Vs Thalidomide/Melphalan/Prednisone In De Novo Multiple Myeloma Patients Not Eligible for ASCT. Blood. 118(21). 5117–5117. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact